Evidence map›Paper›PMID 42046696›Full record

ArticleVeterinary world2026

Protective effects of

S Sahana, Shivaprakash Gangachannaiah, Ravindra Maradi, K G Mohandas Rao, Sangita G Kamath, Shalini Adiga, S Chandana, Monalisa Biswas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Veterinary world, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S SahanaDepartment of Pharmacology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Shivaprakash GangachannaiahDepartment of Pharmacology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Ravindra MaradiDepartment of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
K G Mohandas RaoDepartment of Basic Medical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Sangita G KamathDepartment of Pharmacology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Shalini AdigaDepartment of Pharmacology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
S ChandanaDepartment of Pharmacology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Monalisa BiswasDepartment of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Cisplatin, a platinum-based chemotherapeutic agent, is widely employed in the treatment of various malignancies. However, its clinical utility is restricted by dose-limiting hepatorenal toxicities, primarily driven by oxidative stress, inflammation, and direct cytotoxicity. The present Materials and Methods: Thirty male Wistar rats were randomly divided into five groups (n = 6 per group): control (normal saline), cisplatin (7.5 mg/kg intraperitoneally on day 7), and three intervention groups receiving Results: Administration of Conclusion:

Indexed as

Bacopa monniericisplatin hepatotoxicitycisplatin-induced toxicitycisplatin nephrotoxicityhepatorenal protectionKIM-1 biomarkeroxidative stressrenal injury marker

Identifiers

PMID42046696
PMCPMC13110477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.